{
  "pmcid": "1283103",
  "sha256": "27e3440d9a36030cd7ac28d51946d225c4aa76bebb472f06c371215ee0727508",
  "timestamp_utc": "2025-11-09T22:31:41.045227+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.444000000000003,
    "reading_ease": 32.56200000000004,
    "word_count": 225
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Ketamine and Nefopam for Potentiating Opioid Analgesia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "200 participants were randomised"
      },
      "Participants": {
        "score": 1,
        "evidence": "Participants were adults eligible for opioid analgesia"
      },
      "Intervention": {
        "score": 2,
        "evidence": "100 to receive ketamine 10 mg and 100 to receive nefopam 20 mg"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to compare the efficacy and safety of ketamine and nefopam in potentiating opioid analgesia"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in opioid requirement over 24 hours"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both patients and outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "200 participants were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted on an intention-to-treat basis"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Both ketamine and nefopam reduced opioid requirements by approximately 40% (mean difference = [value], 95% CI [range]; p = [value])"
      },
      "Harms": {
        "score": 1,
        "evidence": "Sedation was observed in the ketamine group, while tachycardia and sweating were noted in the nefopam group"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 1,
        "evidence": "This study was funded by [Funding Source]"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}